Patients who did not receive ATT died in all reviewed cases, and the survival rate was numerically higher in patients receiving both ATT and chemoimmunotherapy than those only receiving ATT, although, the difference did not reach statistical significance.
← all excerpts
Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: A Review of Current Literature.
1
—
—